COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration

COVID-19 Briefings

Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.

Questioning Appropriate SARS-CoV-2 Test Utilization (Part 2)


Mayo Clinic Laboratories is examining if utilization of SARS-CoV-2 serology testing may be optimized when coupled with PCR testing. Dr. Matthew J. Binnicker explains the lab test utilization strategy being evaluated to develop risk profiles and increase risk awareness.